These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9193745

  • 1. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.
    van Vliet IM, Westenberg HG, Slaap BR, den Boer JA, Ho Pian KL.
    Biol Psychiatry; 1997 Jul 01; 42(1):76-8. PubMed ID: 9193745
    [No Abstract] [Full Text] [Related]

  • 2. Anxiety symptoms in panic disorder and social phobia: support for suffocation theory of panic?
    Hazen AL, Stein MB, Walker JR.
    Anxiety; 1996 Jul 01; 2(2):102-5. PubMed ID: 9160610
    [No Abstract] [Full Text] [Related]

  • 3. Phenomenology and neurobiology of social phobia: comparison with panic disorder.
    Uhde TW, Tancer ME, Black B, Brown TM.
    J Clin Psychiatry; 1991 Nov 01; 52 Suppl():31-40. PubMed ID: 1757454
    [Abstract] [Full Text] [Related]

  • 4. Social phobia with sudden onset--post-panic social phobia?
    Kristensen AS, Mortensen EL, Mors O.
    J Anxiety Disord; 2008 May 01; 22(4):684-92. PubMed ID: 17728097
    [Abstract] [Full Text] [Related]

  • 5. Core symptom pattern of social phobia.
    Fahlén T.
    Depress Anxiety; 2008 May 01; 4(5):223-32. PubMed ID: 9167788
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
    McCann UD, Slate SO, Geraci M, Roscow-Terrill D, Uhde TW.
    Neuropsychopharmacology; 1997 Mar 01; 16(3):229-37. PubMed ID: 9138439
    [Abstract] [Full Text] [Related]

  • 7. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA, Koszycki D, Bradwejn J.
    Depress Anxiety; 2004 Mar 01; 20(2):51-8. PubMed ID: 15390214
    [Abstract] [Full Text] [Related]

  • 8. Anxiety sensitivity in social phobia: comparison between social phobics with and without panic attacks.
    Scott EL, Heimberg RG, Jack MS.
    Depress Anxiety; 2000 Mar 01; 12(4):189-92. PubMed ID: 11195754
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK?
    Coupland N, Malizia A, Bailey J, Nutt D.
    Biol Psychiatry; 1996 Mar 15; 39(6):465-6. PubMed ID: 8679797
    [No Abstract] [Full Text] [Related]

  • 10. Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls.
    Tancer ME, Stein MB, Uhde TW.
    Anxiety; 1996 Mar 15; 1(3):138-40. PubMed ID: 9160563
    [No Abstract] [Full Text] [Related]

  • 11. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
    Tancer ME, Stein MB, Uhde TW.
    Biol Psychiatry; 1993 Nov 01; 34(9):591-5. PubMed ID: 8292687
    [Abstract] [Full Text] [Related]

  • 12. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
    Zedkova L, Coupland NJ, Man GC, Dinsa G, Sanghera G.
    Depress Anxiety; 2003 Nov 01; 17(2):78-87. PubMed ID: 12621596
    [Abstract] [Full Text] [Related]

  • 13. Attention bias in children of patients with panic disorder.
    Schneider S, Unnewehr S, In-Albon T, Margraf J.
    Psychopathology; 2008 Nov 01; 41(3):179-86. PubMed ID: 18337628
    [Abstract] [Full Text] [Related]

  • 14. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
    McCann UD, Morgan CM, Geraci M, Slate SO, Murphy DL, Post RM.
    Neuropsychopharmacology; 1997 Dec 01; 17(6):360-9. PubMed ID: 9397424
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
    McManus K, Tait GR, Bellavance F, Le Mellédo JM.
    J Affect Disord; 2001 Oct 01; 66(2-3):273-9. PubMed ID: 11578682
    [Abstract] [Full Text] [Related]

  • 18. Triggering the false suffocation alarm in panic disorder patients by using a voluntary breath-holding procedure.
    Asmundson GJ, Stein MB.
    Am J Psychiatry; 1994 Feb 01; 151(2):264-6. PubMed ID: 8296901
    [Abstract] [Full Text] [Related]

  • 19. Sleep panic attacks: a micro-movement analysis.
    Brown TM, Uhde TW.
    Depress Anxiety; 2003 Feb 01; 18(4):214-20. PubMed ID: 14661191
    [Abstract] [Full Text] [Related]

  • 20. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD, Slate SO, Geraci M, Uhde TW.
    Anxiety; 2003 Feb 01; 1(6):258-67. PubMed ID: 9160584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.